EHop-016是Rac GTP酶Rac1和Rac3的有效选择性抑制剂。它在MDA-MB-435细胞中抑制Rac1活性的IC50为1.1 μM。EHop-016抑制Vav2与Rac的相互作用、Rac介导的PAK1活化、片状脂蛋白形成和细胞迁移。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 靶点 |
|
| 描述 | EHop-016 is a potent and selective inhibitor of Rac GTPase and inhibits Rac1 activity in MDA-MB-435 cells with an IC50 of 1.1 μM. |
| Concentration | Treated Time | Description | References | |
| PC3 cells | 8 µM | 24 hours | EHop-016 inhibits Rac activity in PC3 cells by 50%. | Transl Oncol. 2014 Oct 24;7(5):546-55. |
| MDA-MB-435 cells | 5, 10, 25 µM | 24 hours | EHop-016 significantly increases caspase 3/7 activity at concentrations ≥10μM, indicating it may induce apoptosis. | Transl Oncol. 2014 Oct 24;7(5):546-55. |
| HUVEC cells | 4, 8 µM | 24 hours | EHop-016 reduces tube formation in HUVEC cells at 4 μM, and significantly inhibits tube formation at 8 μM. | Transl Oncol. 2014 Oct 24;7(5):546-55. |
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | Breast cancer model | Intraperitoneal injection | 10, 25 mg/kg | 3 times a week for 8 weeks | EHop-016 significantly reduces mammary fat pad tumor growth and metastasis, and inhibits angiogenesis. | Transl Oncol. 2014 Oct 24;7(5):546-55. |
| NSG mice | Myxofibrosarcoma xenograft | Oral gavage | 15 mg/kg or 20 mg/kg | Twice daily 5 days per week until significant tumor inhibition | Significant inhibition of tumor growth and lung metastasis | Cancer Discov. 2016 Oct;6(10):1148-1165 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.32mL 0.46mL 0.23mL |
11.61mL 2.32mL 1.16mL |
23.23mL 4.65mL 2.32mL |
|
| CAS号 | 1380432-32-5 |
| 分子式 | C25H30N6O |
| 分子量 | 430.55 |
| SMILES Code | CCN1C2=C(C3=C1C=CC=C3)C=C(NC4=NC(NCCCN5CCOCC5)=NC=C4)C=C2 |
| MDL No. | MFCD23143628 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | AFTZZRFCMOAFCR-UHFFFAOYSA-N |
| Pubchem ID | 51031035 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 30 mg/mL(69.68 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1